KAVI-Institute of Clinical Research (KAVI-ICR) was awarded the 2022 International AIDS Vaccine Initiative
(IAVI) External Quality Assessment (EQA) Awards For Tier 1 and Tier 2. This is the second year running
that the Institute has won this prestigious award. It recognizes the best performing laboratories
amongst their Clinical Research Centres in Africa. The Institute at the University of Nairobi, KNH Campus
was first among Tier 1 and the Kangemi site among Tier 2.

Pain management is key in delivering quality health care for patients. This was the
main message during a training conducted by Kenya Hospice and Palliative Care
Association(KEHPCA) on Pain and palliative care. The hybrid training saw more than
100 participants in attendance.
The training targeted this year's finalists to equip them with palliative care
knowledge to deliver better care for their patients as they head out for their
internships.
Prof. Cheserem opened the training officially. She encouraged the finalists to attend

Scholars conducted a study on hematological abnormalities among patients with chronic kidney disease.

The study conducted on 120 patients over a period of six months, revealed that about a third of the patients presented neutrophilia, which is an indication of inflammation in the patient’s body. Microcytic anaemia is the most common haematological abnormality and is likely due to iron deficiency.